Related Experiment Video
Updated: Aug 9, 2025

04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
827
Children and Snakebite: Snake Venom Effects on Adult and Paediatric Plasma
Christina N Zdenek1, Caroline F B Rodrigues2, Lachlan A Bourke1
1Venom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia.
Toxins
|February 24, 2023
Summary
Snakebite venom affects adults and children differently. Russell's Viper venom is more potent in children, while Mulga Snake and Many-horned Adder venoms are more potent in adults.
Area of Science:
- Toxicology
- Hematology
- Herpetology
Background:
- Snakebite envenoming is a neglected tropical disease, primarily causing coagulation disturbances.
- Age-related variations in human plasma are known, but their impact on snakebite pathology is understudied.
Purpose of the Study:
- To investigate age-related differences in human plasma susceptibility to snake venom coagulotoxicity.
- To compare the in vivo clotting effects of diverse snake venoms on adult versus pediatric plasma.
Main Methods:
- Tested venoms from 15 medically significant snake species globally.
- Assessed venom coagulotoxicity by measuring clotting time in adult (18+) and pediatric (median 3.3 years) human plasma.
- Compared venom effects to spontaneous plasma clotting times.
Main Results:
- Russell's Viper (procoagulant) venom showed significantly higher potency in pediatric plasma.
- Mulga Snake and Many-horned Adder (anticoagulant) venoms were significantly more potent in adult plasma.
- Other procoagulant and all pseudo-procoagulant venoms exhibited similar potency across both age groups.
Conclusions:
- Preliminary findings highlight age-dependent variations in plasma response to snake venoms.
- Results may guide future research on snakebite pathophysiology in different age demographics.
- Understanding these differences could help reduce the global burden of snakebite envenoming.
Keywords:
VICCblood coagulationchilddevelopmentelapidenvenomationhemostasispaediatricspediatricsviperMore Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
955
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
955
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Distribution: Plasma Protein Binding
5.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.8K

